Cilostazol vs aspirin
The review found no eligible studies for this question.
- Antithrombotic treatment after stroke due to intracerebral haemorrhage 2023 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
The review found no eligible studies for this question.
Summary of findings table ‐ Cilostazol showed no clear difference in intracerebral haemorrhage (ICH) compared with aspirin (low certainty).
It is very uncertain whether summary of findings table ‐ Starting short‐term prophylactic dose… changes death compared with avoiding anticoagulation (very low certainty).
The review found no eligible studies for this question.
It is very uncertain whether summary of findings table ‐ Starting short‐term prophylactic dose… changes venous thromboembolism compared with avoiding anticoagulation (very low certainty).
It is very uncertain whether summary of findings table ‐ Starting short‐term prophylactic dose… changes intracerebral haemorrhage (ICH) compared with avoiding anticoagulation (very low certainty).
It is very uncertain whether summary of findings table ‐ Starting short‐term prophylactic dose… changes functional status: mRS 0‐2 compared with avoiding anticoagulation (very low certainty).
Summary of findings table ‐ Starting long‐term therapeutic dose oral… probably leads to lower MACE (MACE) compared with avoiding anticoagulation (moderate certainty).
Summary of findings table ‐ Starting long‐term therapeutic dose oral… showed no clear difference in death compared with avoiding anticoagulation (moderate certainty).
Summary of findings table ‐ Starting long‐term therapeutic dose oral… probably leads to lower all major occlusive vascular events compared with avoiding anticoagulation (moderate certainty).
Summary of findings table ‐ Starting long‐term therapeutic dose oral… showed no clear difference in intracranial haemorrhage compared with avoiding anticoagulation (moderate certainty).
Endovascular therapy plus conventional medical treatment probably leads to higher death or stroke compared with conventional medical treatment alone (moderate certainty).
Endovascular therapy plus conventional medical treatment probably leads to higher ipsilateral stroke compared with conventional medical treatment alone (moderate certainty).
Endovascular therapy plus conventional medical treatment showed no clear difference in type of recurrent event compared with conventional medical treatment alone (moderate certainty).
Endovascular therapy plus conventional medical treatment may leads to higher death compared with conventional medical treatment alone (low certainty).
Endovascular therapy plus conventional medical treatment showed no clear difference in dependency compared with conventional medical treatment alone (moderate certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.